tci Medicare Compliance & Reimbursement - 2006 Issue 27
ONCOLOGISTS: You Have Representatives On Your Side In Cancer-Care Crisis
Subscribe or sign in to view the full article.
Article Overview
This article covers a House Ways & Means Health Subcommittee hearing in which lawmakers questioned CMS officials about oncology reimbursement, payment policy, and patient access issues. It is relevant to oncology practices, Medicare policy watchers, and coding/reimbursement professionals following cancer-care administration fees, demonstration projects, and IVIG coverage concerns. The discussion also touches on broader advocacy positions raised by oncology organizations and CMS responses to stakeholder concerns.
Why This Topic Matters
It helps readers understand the policy and reimbursement issues driving access concerns in cancer care and related infusion services, especially for those tracking Medicare payment changes and CMS guidance.
Article Sections
-
Congressional hearing on oncology payment concerns
Lawmakers and CMS officials discuss broad Medicare payment issues affecting cancer care delivery and oncology practices.
-
Discussion of IVIG access and CMS response
The article covers access concerns for intravenous immune globulin and the agency’s reported actions with stakeholders and manufacturers.
-
Stakeholder and legislative proposals
The article summarizes advocacy points from oncology groups and suggestions raised during the hearing about Medicare payment policy.
What You Will Learn
- The main Medicare policy issues discussed in relation to oncology care
- How CMS and congressional members framed access concerns for infusion-related services
- Which stakeholder groups and legislative ideas were part of the hearing discussion
- The broader reimbursement context affecting cancer treatment administration and related services
Who Should Read This
- Oncology practices
- Medical coders
- Billing and reimbursement staff
- Health policy professionals
- Medicare compliance teams
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com